Skip to main content
Erschienen in: Head and Neck Pathology 4/2014

01.12.2014 | Update in Gnathic Pathology. Guest Editors: Angela Chi, DMD and John Wright, DDS

Metastatic Tumors to the Jaws and Mouth

verfasst von: Abraham Hirshberg, Raanan Berger, Irit Allon, Ilana Kaplan

Erschienen in: Head and Neck Pathology | Ausgabe 4/2014

Einloggen, um Zugang zu erhalten

Abstract

Metastatic dissemination to the oral cavity is rare and is usually the evidence of a wide spread disease with an average survival rate of 7 months. In almost a quarter of the cases, oral metastasis was found to be the first indication of an occult malignancy at a distant site. Metastatic lesions can be found anywhere in the oral cavity, however, the jawbones with the molar area is the most frequently involved site. In the oral soft tissues, the gingiva is the most common site, suggesting the possible role of inflammation in the attraction of metastatic deposits. The most common primary malignancies presenting oral metastases were the lung, kidney, liver, and prostate for men, and breast, female genital organs, kidney, and colo-rectum for women. Most patients with jawbone metastasis complain of swelling, pain, and paresthesia. An exophytic lesion is the most common clinical presentation of metastatic lesions in the oral soft tissues. Early lesions, mainly those located in the gingiva, may resemble a hyperplastic or reactive lesion. Once a lesion is recognized as metastasis, the primary tumor site should be identified following clinical, radiological and histopathological investigations. If standardized diagnostic workup fails to detect the site of origin, then the term carcinoma of unknown primary is applied. Personalized medicine tools such as tissue-of-origin assays should be applied, either by immunohistochemical testing or by molecular-profiling methods as these may lead to a more favorable outcome.
Literatur
2.
Zurück zum Zitat Nguyen DX, Bos PD, Massague J. Metastasis: from dissemination to organ-specific colonization. Nat Rev Cancer. 2009;9(4):274–84.PubMedCrossRef Nguyen DX, Bos PD, Massague J. Metastasis: from dissemination to organ-specific colonization. Nat Rev Cancer. 2009;9(4):274–84.PubMedCrossRef
3.
Zurück zum Zitat Hanahan D, Weinberg RA. Hallmarks of cancer: the next generation. Cell. 2011;144(5):646–74.PubMedCrossRef Hanahan D, Weinberg RA. Hallmarks of cancer: the next generation. Cell. 2011;144(5):646–74.PubMedCrossRef
4.
Zurück zum Zitat Servato JP, de Paulo LF, de Faria PR, Cardoso SV, Loyola AM. Metastatic tumours to the head and neck: retrospective analysis from a Brazilian tertiary referral centre. Int J Oral Maxillofac Surg. 2013;42(11):1391–6.PubMedCrossRef Servato JP, de Paulo LF, de Faria PR, Cardoso SV, Loyola AM. Metastatic tumours to the head and neck: retrospective analysis from a Brazilian tertiary referral centre. Int J Oral Maxillofac Surg. 2013;42(11):1391–6.PubMedCrossRef
5.
Zurück zum Zitat Hashimoto N, Kurihara K, Yamasaki H, Ohba S, Sakai H, Yoshida S. Pathological characteristics of metastatic carcinoma in the human mandible. J Oral Pathol. 1987;16(7):362–7.PubMedCrossRef Hashimoto N, Kurihara K, Yamasaki H, Ohba S, Sakai H, Yoshida S. Pathological characteristics of metastatic carcinoma in the human mandible. J Oral Pathol. 1987;16(7):362–7.PubMedCrossRef
6.
Zurück zum Zitat Hirshberg A, Leibovich P, Buchner A. Metastases to the oral mucosa: analysis of 157 cases. J Oral Pathol Med. 1993;22(9):385–90.PubMedCrossRef Hirshberg A, Leibovich P, Buchner A. Metastases to the oral mucosa: analysis of 157 cases. J Oral Pathol Med. 1993;22(9):385–90.PubMedCrossRef
7.
Zurück zum Zitat Hirshberg A, Leibovich P, Buchner A. Metastatic tumors to the jaws: analysis of 390 cases. J Oral Pathol Med. 1994;23(8):337–41.PubMedCrossRef Hirshberg A, Leibovich P, Buchner A. Metastatic tumors to the jaws: analysis of 390 cases. J Oral Pathol Med. 1994;23(8):337–41.PubMedCrossRef
8.
Zurück zum Zitat Hirshberg A, Buchner A. Metastatic tumours to the oral region. An overview. Oral Oncol. Eur J Cancer. 1995;31B(6):355–60.CrossRef Hirshberg A, Buchner A. Metastatic tumours to the oral region. An overview. Oral Oncol. Eur J Cancer. 1995;31B(6):355–60.CrossRef
9.
Zurück zum Zitat Hirshberg A, Shnaiderman-Shapiro A, Kaplan I, Berger R. Metastatic tumours to the oral cavity—pathogenesis and analysis of 673 cases. Oral Oncol. 2008;44(8):743–52.PubMedCrossRef Hirshberg A, Shnaiderman-Shapiro A, Kaplan I, Berger R. Metastatic tumours to the oral cavity—pathogenesis and analysis of 673 cases. Oral Oncol. 2008;44(8):743–52.PubMedCrossRef
10.
Zurück zum Zitat Allon I, Pessing A, Kaplan I, Allon DM, Hirshberg A. Metastatic tumors to the gingiva and the presence of teeth as a contributing factor: a literature analysis. J Periodontol. 2014;85(1):132–9.PubMedCrossRef Allon I, Pessing A, Kaplan I, Allon DM, Hirshberg A. Metastatic tumors to the gingiva and the presence of teeth as a contributing factor: a literature analysis. J Periodontol. 2014;85(1):132–9.PubMedCrossRef
12.
Zurück zum Zitat Baccelli I, Schneeweiss A, Riethdorf S, Stenzinger A, Schillert A, Vogel V, Klein C, Saini M, Bäuerle T, Wallwiener M, Holland-Letz T, Höfner T, Sprick M, Scharpff M, Marmé F, Sinn HP, Pantel K, Weichert W, Trumpp A. Identification of a population of blood circulating tumor cells from breast cancer patients that initiates metastasis in a xenograft assay. Nat Biotechnol. 2013;31(6):539–44.PubMedCrossRef Baccelli I, Schneeweiss A, Riethdorf S, Stenzinger A, Schillert A, Vogel V, Klein C, Saini M, Bäuerle T, Wallwiener M, Holland-Letz T, Höfner T, Sprick M, Scharpff M, Marmé F, Sinn HP, Pantel K, Weichert W, Trumpp A. Identification of a population of blood circulating tumor cells from breast cancer patients that initiates metastasis in a xenograft assay. Nat Biotechnol. 2013;31(6):539–44.PubMedCrossRef
13.
Zurück zum Zitat Stott SL, Lee RJ, Nagrath S, Yu M, Miyamoto DT, Ulkus L, Inserra EJ, Ulman M, Springer S, Nakamura Z, Moore AL, Tsukrov DI, Kempner ME, Dahl DM, Wu CL, Iafrate AJ, Smith MR, Tompkins RG, Sequist LV, Toner M, Haber DA, Maheswaran S. Isolation and characterization of circulating tumor cells from patients with localized and metastatic prostate cancer. Sci Transl Med. 2010;2(25):25.CrossRef Stott SL, Lee RJ, Nagrath S, Yu M, Miyamoto DT, Ulkus L, Inserra EJ, Ulman M, Springer S, Nakamura Z, Moore AL, Tsukrov DI, Kempner ME, Dahl DM, Wu CL, Iafrate AJ, Smith MR, Tompkins RG, Sequist LV, Toner M, Haber DA, Maheswaran S. Isolation and characterization of circulating tumor cells from patients with localized and metastatic prostate cancer. Sci Transl Med. 2010;2(25):25.CrossRef
14.
Zurück zum Zitat Sleeman JP, Nazarenko I, Thiele W. Do all roads lead to Rome? Routes to metastasis development. Int J Cancer. 2011;128(11):2511–26.PubMedCrossRef Sleeman JP, Nazarenko I, Thiele W. Do all roads lead to Rome? Routes to metastasis development. Int J Cancer. 2011;128(11):2511–26.PubMedCrossRef
18.
Zurück zum Zitat Thiery JP, Acloque H, Huang RY, Nieto MA. Epithelial-mesenchymal transitions in development and disease. Cell. 2009;139(5):871–90.PubMedCrossRef Thiery JP, Acloque H, Huang RY, Nieto MA. Epithelial-mesenchymal transitions in development and disease. Cell. 2009;139(5):871–90.PubMedCrossRef
20.
Zurück zum Zitat Folkman J. Role of angiogenesis in tumor growth and metastasis. Semin Oncol. 2002;29(6 Suppl 16):15–8.PubMedCrossRef Folkman J. Role of angiogenesis in tumor growth and metastasis. Semin Oncol. 2002;29(6 Suppl 16):15–8.PubMedCrossRef
21.
Zurück zum Zitat Weis SM, Cheresh DA. Tumor angiogenesis: molecular pathways and therapeutic targets. Nat Med. 2011;17(11):1359–70.PubMedCrossRef Weis SM, Cheresh DA. Tumor angiogenesis: molecular pathways and therapeutic targets. Nat Med. 2011;17(11):1359–70.PubMedCrossRef
23.
Zurück zum Zitat Pugh CW, Ratcliffe PJ. Regulation of angiogenesis by hypoxia: role of the HIF system. Nat Med. 2003;9(6):677–84.PubMedCrossRef Pugh CW, Ratcliffe PJ. Regulation of angiogenesis by hypoxia: role of the HIF system. Nat Med. 2003;9(6):677–84.PubMedCrossRef
24.
Zurück zum Zitat Reymond N, d’Água BB, Ridley AJ. Crossing the endothelial barrier during metastasis. Nat Rev Cancer. 2013;13(12):858–70.PubMedCrossRef Reymond N, d’Água BB, Ridley AJ. Crossing the endothelial barrier during metastasis. Nat Rev Cancer. 2013;13(12):858–70.PubMedCrossRef
25.
Zurück zum Zitat Nguyen DX, Bos PD, Massague J. Metastasis: from dissemination to organ-specific colonization. Nat Rev Cancer. 2009;9(4):274–84.PubMedCrossRef Nguyen DX, Bos PD, Massague J. Metastasis: from dissemination to organ-specific colonization. Nat Rev Cancer. 2009;9(4):274–84.PubMedCrossRef
26.
Zurück zum Zitat Paget S. The distribution of secondary growths in cancer of the breast. Lancet. 1889;1:571–3.CrossRef Paget S. The distribution of secondary growths in cancer of the breast. Lancet. 1889;1:571–3.CrossRef
28.
Zurück zum Zitat Aggarwal BB, Shishodia S, Sandur SK, Pandey MK, Sethi G. Inflammation and cancer: how hot is the link? Biochem Pharmacol. 2006;72(11):1605–21.PubMedCrossRef Aggarwal BB, Shishodia S, Sandur SK, Pandey MK, Sethi G. Inflammation and cancer: how hot is the link? Biochem Pharmacol. 2006;72(11):1605–21.PubMedCrossRef
29.
Zurück zum Zitat Spano D, Zollo M. Tumor microenvironment: a main actor in the metastasis process. Clin Exp Metastasis. 2012;29(4):381–95.PubMedCrossRef Spano D, Zollo M. Tumor microenvironment: a main actor in the metastasis process. Clin Exp Metastasis. 2012;29(4):381–95.PubMedCrossRef
30.
Zurück zum Zitat Borsig L, Wolf MJ, Roblek M, Lorentzen A, Heikenwalder M. Inflammatory chemokines and metastasis–tracing the accessory. Oncogene. 2014;33(25):3217–24.PubMedCrossRef Borsig L, Wolf MJ, Roblek M, Lorentzen A, Heikenwalder M. Inflammatory chemokines and metastasis–tracing the accessory. Oncogene. 2014;33(25):3217–24.PubMedCrossRef
31.
Zurück zum Zitat Elinav E, Nowarski R, Thaiss CA, Hu B, Jin C, Flavell RA. Inflammation-induced cancer: crosstalk between tumours, immune cells and microorganisms. Nat Rev Cancer. 2013;13(11):759–71.PubMedCrossRef Elinav E, Nowarski R, Thaiss CA, Hu B, Jin C, Flavell RA. Inflammation-induced cancer: crosstalk between tumours, immune cells and microorganisms. Nat Rev Cancer. 2013;13(11):759–71.PubMedCrossRef
32.
Zurück zum Zitat Peinado H, Lavotshkin S, Lyden D. The secreted factors responsible for pre-metastatic niche formation: old sayings and new thoughts. Semin Cancer Biol. 2011;21(2):139–46.PubMedCrossRef Peinado H, Lavotshkin S, Lyden D. The secreted factors responsible for pre-metastatic niche formation: old sayings and new thoughts. Semin Cancer Biol. 2011;21(2):139–46.PubMedCrossRef
33.
Zurück zum Zitat Landskron G, De la Fuente M, Thuwajit P, Thuwajit C, Hermoso MA. Chronic inflammation and cytokines in the tumor microenvironment. J Immunol Res. 2014;2014:149185.PubMedCentralPubMedCrossRef Landskron G, De la Fuente M, Thuwajit P, Thuwajit C, Hermoso MA. Chronic inflammation and cytokines in the tumor microenvironment. J Immunol Res. 2014;2014:149185.PubMedCentralPubMedCrossRef
34.
Zurück zum Zitat Stockmann C, Schadendorf D, Klose R, Helfrich I. The impact of the immune system on tumor: angiogenesis and vascular remodeling. Front Oncol. 2014;4:69.PubMedCentralPubMedCrossRef Stockmann C, Schadendorf D, Klose R, Helfrich I. The impact of the immune system on tumor: angiogenesis and vascular remodeling. Front Oncol. 2014;4:69.PubMedCentralPubMedCrossRef
35.
Zurück zum Zitat Feller L, Altini M, Lemmer J. Inflammation in the context of oral cancer. Oral Oncol. 2013;49(9):887–92.PubMedCrossRef Feller L, Altini M, Lemmer J. Inflammation in the context of oral cancer. Oral Oncol. 2013;49(9):887–92.PubMedCrossRef
36.
Zurück zum Zitat Tezal M, Sullivan MA, Hyland A, Marshall JR, Stoler D, Reid ME, Loree TR, Rigual NR, Merzianu M, Hauck L, Lillis C, Wactawski-Wende J, Scannapieco FA. Chronic periodontitis and the incidence of head and neck squamous cell carcinoma. Cancer Epidemiol Biomarkers Prev. 2009;18(9):2406–12.PubMedCrossRef Tezal M, Sullivan MA, Hyland A, Marshall JR, Stoler D, Reid ME, Loree TR, Rigual NR, Merzianu M, Hauck L, Lillis C, Wactawski-Wende J, Scannapieco FA. Chronic periodontitis and the incidence of head and neck squamous cell carcinoma. Cancer Epidemiol Biomarkers Prev. 2009;18(9):2406–12.PubMedCrossRef
37.
38.
Zurück zum Zitat Coleman RE. Clinical features of metastatic bone disease and risk of skeletal morbidity. Clin Cancer Res. 2006;12(20 Pt 2):6243s–9s.PubMedCrossRef Coleman RE. Clinical features of metastatic bone disease and risk of skeletal morbidity. Clin Cancer Res. 2006;12(20 Pt 2):6243s–9s.PubMedCrossRef
39.
Zurück zum Zitat Li S, Peng Y, Weinhandl ED, Blaes AH, Cetin K, Chia VM, Stryker S, Pinzone JJ, Acquavella JF, Arneson TJ. Estimated number of prevalent cases of metastatic bone disease in the US adult population. Clin Epidemiol. 2012;4:87–93.PubMedCentralPubMed Li S, Peng Y, Weinhandl ED, Blaes AH, Cetin K, Chia VM, Stryker S, Pinzone JJ, Acquavella JF, Arneson TJ. Estimated number of prevalent cases of metastatic bone disease in the US adult population. Clin Epidemiol. 2012;4:87–93.PubMedCentralPubMed
40.
Zurück zum Zitat Rahim F, Hajizamani S, Mortaz E, Ahmadzadeh A, Shahjahani M, Shahrabi S, Saki N. Molecular regulation of bone marrow metastasis in prostate and breast cancer. Bone Marrow Res. 2014;2014:405920.PubMedCentralPubMedCrossRef Rahim F, Hajizamani S, Mortaz E, Ahmadzadeh A, Shahjahani M, Shahrabi S, Saki N. Molecular regulation of bone marrow metastasis in prostate and breast cancer. Bone Marrow Res. 2014;2014:405920.PubMedCentralPubMedCrossRef
41.
Zurück zum Zitat Brown JE, Cook RJ, Major P, Lipton A, Saad F, Smith M, Lee KA, Zheng M, Hei YJ, Coleman RE. Bone turnover markers as predictors of skeletal complications in prostate cancer, lung cancer, and other solid tumors. J Natl Cancer Inst. 2005;97(1):59–69.PubMedCrossRef Brown JE, Cook RJ, Major P, Lipton A, Saad F, Smith M, Lee KA, Zheng M, Hei YJ, Coleman RE. Bone turnover markers as predictors of skeletal complications in prostate cancer, lung cancer, and other solid tumors. J Natl Cancer Inst. 2005;97(1):59–69.PubMedCrossRef
42.
Zurück zum Zitat Dougall WC. Molecular pathways: osteoclast-dependent and osteoclast-independent roles of the RANKL/RANK/OPG pathway in tumorigenesis and metastasis. Clin Cancer Res. 2011;18(2):326–35.PubMedCrossRef Dougall WC. Molecular pathways: osteoclast-dependent and osteoclast-independent roles of the RANKL/RANK/OPG pathway in tumorigenesis and metastasis. Clin Cancer Res. 2011;18(2):326–35.PubMedCrossRef
43.
Zurück zum Zitat Rucci N, Teti A. Osteomimicry: how tumor cells try to deceive the bone. Front Biosci (Schol Ed). 2010;1(2):907–15.CrossRef Rucci N, Teti A. Osteomimicry: how tumor cells try to deceive the bone. Front Biosci (Schol Ed). 2010;1(2):907–15.CrossRef
44.
Zurück zum Zitat Clezardin P, Teti A. Bone metastasis: pathogenesis and therapeutic implications. Clin Exp Metastasis. 2007;24(8):599–608.PubMedCrossRef Clezardin P, Teti A. Bone metastasis: pathogenesis and therapeutic implications. Clin Exp Metastasis. 2007;24(8):599–608.PubMedCrossRef
47.
Zurück zum Zitat Gartrell BA, Saad F. Managing bone metastases and reducing skeletal related events in prostate cancer. Nat Rev Clin Oncol. 2014;11(6):335–45.PubMedCrossRef Gartrell BA, Saad F. Managing bone metastases and reducing skeletal related events in prostate cancer. Nat Rev Clin Oncol. 2014;11(6):335–45.PubMedCrossRef
48.
Zurück zum Zitat Yonou H, Ochiai A, Goya M, Kanomata N, Hokama S, Morozumi M, Sugaya K, Hatano T, Ogawa Y. Intraosseous growth of human prostate cancer in implanted adult human bone: relationship of prostate cancer cells to osteoclasts in osteoblastic metastatic lesions. Prostate. 2004;58(4):406–13.PubMedCrossRef Yonou H, Ochiai A, Goya M, Kanomata N, Hokama S, Morozumi M, Sugaya K, Hatano T, Ogawa Y. Intraosseous growth of human prostate cancer in implanted adult human bone: relationship of prostate cancer cells to osteoclasts in osteoblastic metastatic lesions. Prostate. 2004;58(4):406–13.PubMedCrossRef
49.
Zurück zum Zitat Jung K, Lein M. Bone turnover markers in serum and urine as diagnostic, prognostic and monitoring biomarkers of bone metastasis. Biochim Biophys Acta. 2014;1846(2):425–38.PubMed Jung K, Lein M. Bone turnover markers in serum and urine as diagnostic, prognostic and monitoring biomarkers of bone metastasis. Biochim Biophys Acta. 2014;1846(2):425–38.PubMed
50.
Zurück zum Zitat Coleman R, Costa L, Saad F, Cook R, Hadji P, Terpos E, Garnero P, Brown J, Body JJ, Smith M, Lee KA, Major P, Dimopoulos M, Lipton A. Consensus on the utility of bone markers in the malignant bone disease setting. Crit Rev Oncol Hematol. 2011;80(3):411–32.PubMedCrossRef Coleman R, Costa L, Saad F, Cook R, Hadji P, Terpos E, Garnero P, Brown J, Body JJ, Smith M, Lee KA, Major P, Dimopoulos M, Lipton A. Consensus on the utility of bone markers in the malignant bone disease setting. Crit Rev Oncol Hematol. 2011;80(3):411–32.PubMedCrossRef
51.
Zurück zum Zitat Barnadas A, Manso L, de la Piedra C, Meseguer C, Crespo C, Gómez P, Calvo L, Martinez P, Ruiz-Borrego M, Perelló A, Antón A, Codes M, Margelí M, Murias A, Salvador J, Seguí MÁ, de Juan A, Gavilá J, Luque M, Pérez D, Zamora P, Arizcuma A, Chacón JI, Heras L, Martin-Fernández M, Mahillo-Fernández I, Tusquets I. Bone turnover markers as predictive indicators of outcome in patients with breast cancer and bone metastases treated with bisphosphonates: results from a 2-year multicentre observational study (ZOMAR study). Bone. 2014;68:32–40.PubMedCrossRef Barnadas A, Manso L, de la Piedra C, Meseguer C, Crespo C, Gómez P, Calvo L, Martinez P, Ruiz-Borrego M, Perelló A, Antón A, Codes M, Margelí M, Murias A, Salvador J, Seguí MÁ, de Juan A, Gavilá J, Luque M, Pérez D, Zamora P, Arizcuma A, Chacón JI, Heras L, Martin-Fernández M, Mahillo-Fernández I, Tusquets I. Bone turnover markers as predictive indicators of outcome in patients with breast cancer and bone metastases treated with bisphosphonates: results from a 2-year multicentre observational study (ZOMAR study). Bone. 2014;68:32–40.PubMedCrossRef
52.
Zurück zum Zitat Poon M, Zeng L, Zhang L, Lam H, Emmenegger U, Wong E, Bedard G, Lao N, Chow R, Chow E. Incidence of skeletal-related events over time from solid tumour bone metastases reported in randomised trials using bone-modifying agents. Clin Oncol (R Coll Radiol). 2013;25(7):435–44.CrossRef Poon M, Zeng L, Zhang L, Lam H, Emmenegger U, Wong E, Bedard G, Lao N, Chow R, Chow E. Incidence of skeletal-related events over time from solid tumour bone metastases reported in randomised trials using bone-modifying agents. Clin Oncol (R Coll Radiol). 2013;25(7):435–44.CrossRef
53.
Zurück zum Zitat Peddi P, Lopez-Olivo MA, Pratt GF, Suarez-Almazor ME. Denosumab in patients with cancer and skeletal metastases: a systematic review and meta-analysis. Cancer Treat Rev. 2013;39(1):97–104.PubMedCentralPubMedCrossRef Peddi P, Lopez-Olivo MA, Pratt GF, Suarez-Almazor ME. Denosumab in patients with cancer and skeletal metastases: a systematic review and meta-analysis. Cancer Treat Rev. 2013;39(1):97–104.PubMedCentralPubMedCrossRef
54.
Zurück zum Zitat Deng X, He G, Liu J, Luo F, Peng X, Tang S, Gao Z, Lin Q, Keller JM, Yang T, Keller ET. Recent advances in bone-targeted therapies of metastatic prostate cancer. Cancer Treat Rev. 2014;40(6):730–8.PubMedCrossRef Deng X, He G, Liu J, Luo F, Peng X, Tang S, Gao Z, Lin Q, Keller JM, Yang T, Keller ET. Recent advances in bone-targeted therapies of metastatic prostate cancer. Cancer Treat Rev. 2014;40(6):730–8.PubMedCrossRef
56.
Zurück zum Zitat Cummings J, Hacking N, Fairhurst J, Ackery D, Jenkins JD. Distribution of bony metastases in prostatic carcinoma. Br J Urol. 1990;66(4):411–4.CrossRef Cummings J, Hacking N, Fairhurst J, Ackery D, Jenkins JD. Distribution of bony metastases in prostatic carcinoma. Br J Urol. 1990;66(4):411–4.CrossRef
57.
Zurück zum Zitat D’silva N, Summerline DJ, Cordell KG, Abdelsayed RA, Tomish CE, Hanks CT, Fear D, Meyrowitz S. Metastatic tumors in the jaws. A retrospective study of 114 cases. JADA. 2006;137(12):1667–72.PubMed D’silva N, Summerline DJ, Cordell KG, Abdelsayed RA, Tomish CE, Hanks CT, Fear D, Meyrowitz S. Metastatic tumors in the jaws. A retrospective study of 114 cases. JADA. 2006;137(12):1667–72.PubMed
58.
Zurück zum Zitat Seoane J, Van der Waal I, Van der Waal RI, Cameselle-Teijeiro J, Antón I, Tardio A, Alcázar-Otero JJ, Varela-Centelles P, Diz P, Antón I, Tardio A, Alcázar-Otero JJ. Metastatic tumours to the oral cavity: a survival study with a special focus on gingival metastases. J Clin Periodontol. 2009;36(6):488–92.PubMedCrossRef Seoane J, Van der Waal I, Van der Waal RI, Cameselle-Teijeiro J, Antón I, Tardio A, Alcázar-Otero JJ, Varela-Centelles P, Diz P, Antón I, Tardio A, Alcázar-Otero JJ. Metastatic tumours to the oral cavity: a survival study with a special focus on gingival metastases. J Clin Periodontol. 2009;36(6):488–92.PubMedCrossRef
59.
Zurück zum Zitat Otenio CC, Fonseca I, Martins MF, Ribeiro LC, Assis NM, Ferreira AP, Ribeiro RA. Expression of IL-1β, IL-6, TNF-α, and iNOS in pregnant women with periodontal disease. Genet Mol Res. 2012;11(4):4468–78.PubMedCrossRef Otenio CC, Fonseca I, Martins MF, Ribeiro LC, Assis NM, Ferreira AP, Ribeiro RA. Expression of IL-1β, IL-6, TNF-α, and iNOS in pregnant women with periodontal disease. Genet Mol Res. 2012;11(4):4468–78.PubMedCrossRef
60.
Zurück zum Zitat Bickel M, Axtelius B, Solioz C, Attstrom R. Cytokine gene expression in chronic periodontitis. J Clin Periodontol. 2001;28(9):840–7.PubMedCrossRef Bickel M, Axtelius B, Solioz C, Attstrom R. Cytokine gene expression in chronic periodontitis. J Clin Periodontol. 2001;28(9):840–7.PubMedCrossRef
61.
Zurück zum Zitat Allavena P, Sica A, Solinas G, Porta C, Mantovani A. The inflammatory microenvironment in tumor progression: the role of tumor-associated macrophages. Crit Rev Oncol Hematol. 2008;66(1):1–9.PubMedCrossRef Allavena P, Sica A, Solinas G, Porta C, Mantovani A. The inflammatory microenvironment in tumor progression: the role of tumor-associated macrophages. Crit Rev Oncol Hematol. 2008;66(1):1–9.PubMedCrossRef
62.
Zurück zum Zitat Siegel R, Naishadham D, Jemal A. Cancer Statistics, 2013. CA Cancer J Clin. 2013;63(1):11–30.PubMedCrossRef Siegel R, Naishadham D, Jemal A. Cancer Statistics, 2013. CA Cancer J Clin. 2013;63(1):11–30.PubMedCrossRef
63.
Zurück zum Zitat Ferlay J, Steliarova-Foucher E, Lortet-Tieulent J, Rosso S, Coebergh JW, Comber H, Forman D, Bray F. Cancer incidence and mortality patterns in Europe: estimates for 40 countries in 2012. Eur J Cancer. 2013;49(6):1374–403.PubMedCrossRef Ferlay J, Steliarova-Foucher E, Lortet-Tieulent J, Rosso S, Coebergh JW, Comber H, Forman D, Bray F. Cancer incidence and mortality patterns in Europe: estimates for 40 countries in 2012. Eur J Cancer. 2013;49(6):1374–403.PubMedCrossRef
64.
Zurück zum Zitat Lim SY, Kim SA, Ahn SG, Kim HK, Kim SG, Hwang HK, Kim BO, Lee SH, Kim JD, Yoon JH. Metastatic tumours to the jaws and oral soft tissues: a retrospective analysis of 41 Korean patients. Int J Oral Maxillofac Surg. 2006;35(5):412–5.PubMedCrossRef Lim SY, Kim SA, Ahn SG, Kim HK, Kim SG, Hwang HK, Kim BO, Lee SH, Kim JD, Yoon JH. Metastatic tumours to the jaws and oral soft tissues: a retrospective analysis of 41 Korean patients. Int J Oral Maxillofac Surg. 2006;35(5):412–5.PubMedCrossRef
65.
Zurück zum Zitat Nishimura Y, Yakata H, Kawasaki T, Nakajima T. Metastatic tumours of the mouth and jaws. A review of the Japanese literature. J Maxillofac Surg. 1982;10(4):253–8.PubMedCrossRef Nishimura Y, Yakata H, Kawasaki T, Nakajima T. Metastatic tumours of the mouth and jaws. A review of the Japanese literature. J Maxillofac Surg. 1982;10(4):253–8.PubMedCrossRef
66.
Zurück zum Zitat Shen ML, Kang J, Wen YL, Ying WM, Yi J, Hua CG, Tang XF, Wen YM. Metastatic tumors to the oral and maxillofacial region: a retrospective study of 19 cases in West China and review of the Chinese and English literature. J Oral Maxillofac Surg. 2009;67(4):718–37.PubMedCrossRef Shen ML, Kang J, Wen YL, Ying WM, Yi J, Hua CG, Tang XF, Wen YM. Metastatic tumors to the oral and maxillofacial region: a retrospective study of 19 cases in West China and review of the Chinese and English literature. J Oral Maxillofac Surg. 2009;67(4):718–37.PubMedCrossRef
67.
Zurück zum Zitat Laurencet FM, Anchisi S, Tullen E, Dietrich PY. Mental neuropathy: report of five cases and review of the literature. Crit Rev Oncol Hematol. 2000;34(1):71–9.PubMedCrossRef Laurencet FM, Anchisi S, Tullen E, Dietrich PY. Mental neuropathy: report of five cases and review of the literature. Crit Rev Oncol Hematol. 2000;34(1):71–9.PubMedCrossRef
68.
Zurück zum Zitat Smith SF, Blackman G, Hopper C. Numb chin syndrome: a nonmetastatic neurological manifestation of malignancy. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2008;105(3):e53–6.PubMedCrossRef Smith SF, Blackman G, Hopper C. Numb chin syndrome: a nonmetastatic neurological manifestation of malignancy. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2008;105(3):e53–6.PubMedCrossRef
69.
Zurück zum Zitat Ahsar A, Khateery SM, Kovacs A. Mandibular metastatic hepatocellular carcinoma: a case involving severe post biopsy hemorrhage. J Oral Maxillofac Surg. 1997;55(6):547–52.CrossRef Ahsar A, Khateery SM, Kovacs A. Mandibular metastatic hepatocellular carcinoma: a case involving severe post biopsy hemorrhage. J Oral Maxillofac Surg. 1997;55(6):547–52.CrossRef
70.
Zurück zum Zitat Hirshberg A, Leibovich P, Horowitz I, Buchner A. metastatic tumors to post-extraction site. J Oral Maxillofac Surg. 1993;51(12):1334–7.PubMedCrossRef Hirshberg A, Leibovich P, Horowitz I, Buchner A. metastatic tumors to post-extraction site. J Oral Maxillofac Surg. 1993;51(12):1334–7.PubMedCrossRef
71.
Zurück zum Zitat Ost P, Bossi A, Decaestecker K, De Meerleer G, Giannarini G, Karnes RJ, Roach M 3rd, Briganti A. Metastasis-directed therapy of regional and distant recurrences after curative treatment of prostate cancer: a systematic review of the literature. Eur Urol. 2014. doi:10.1016/j.eururo.2014.09.004. Ost P, Bossi A, Decaestecker K, De Meerleer G, Giannarini G, Karnes RJ, Roach M 3rd, Briganti A. Metastasis-directed therapy of regional and distant recurrences after curative treatment of prostate cancer: a systematic review of the literature. Eur Urol. 2014. doi:10.​1016/​j.​eururo.​2014.​09.​004.
72.
Zurück zum Zitat Nakamura T, Ishimaru JI, Mizui T, Kobayashi A, Iwata H, Shimokawa K. Osteosarcoma metastatic to the mandible: a case report. Oral Pathol Oral Radiol Endod. 2001;91(4):452–4.CrossRef Nakamura T, Ishimaru JI, Mizui T, Kobayashi A, Iwata H, Shimokawa K. Osteosarcoma metastatic to the mandible: a case report. Oral Pathol Oral Radiol Endod. 2001;91(4):452–4.CrossRef
73.
Zurück zum Zitat Bhattacharyya I, Williamson A, Cohen DM, Bever JL. Metastatic neuroblastoma with ganglionuromtous differentiation and mandibular involvement. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 1999;88(5):582–6.CrossRef Bhattacharyya I, Williamson A, Cohen DM, Bever JL. Metastatic neuroblastoma with ganglionuromtous differentiation and mandibular involvement. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 1999;88(5):582–6.CrossRef
74.
Zurück zum Zitat Taylor MB, Bronham NR, Arnold SE. Carcinoma of unknown primary: key radiological issues from the recent National Institute for Health and Clinical Excellence guidelines. Br J Radiol. 1014;2012(85):661–71. Taylor MB, Bronham NR, Arnold SE. Carcinoma of unknown primary: key radiological issues from the recent National Institute for Health and Clinical Excellence guidelines. Br J Radiol. 1014;2012(85):661–71.
75.
Zurück zum Zitat National Institute for Health and Clinical Excellence. Diagnosis and management of metastatic disease of unknown primary origin (clinical guideline 104). London UK: National Institute for Health and Clinical Excellence; 2010. National Institute for Health and Clinical Excellence. Diagnosis and management of metastatic disease of unknown primary origin (clinical guideline 104). London UK: National Institute for Health and Clinical Excellence; 2010.
76.
Zurück zum Zitat Amela EY, Lauridant-Philippin G, Cousin S, Ryckewaert T, Adenis A, Penel A. Management of “unfavourable” carcinoma of unknown primary site: synthesis of recent literarture. Crit Rev Oncol Hematol. 2012;84(2):213–23.PubMedCrossRef Amela EY, Lauridant-Philippin G, Cousin S, Ryckewaert T, Adenis A, Penel A. Management of “unfavourable” carcinoma of unknown primary site: synthesis of recent literarture. Crit Rev Oncol Hematol. 2012;84(2):213–23.PubMedCrossRef
77.
Zurück zum Zitat Rekhtman N, Bishop JA. Quick reference handbook for surgical pathologists. Berlin: Springer; 2011.CrossRef Rekhtman N, Bishop JA. Quick reference handbook for surgical pathologists. Berlin: Springer; 2011.CrossRef
78.
Zurück zum Zitat Pavilidis N, Pentheroudokis G. Cancer of unknown primary site. Lancet. 2012;379:1428–35.CrossRef Pavilidis N, Pentheroudokis G. Cancer of unknown primary site. Lancet. 2012;379:1428–35.CrossRef
79.
Zurück zum Zitat Pepper C, Pai I, Hay A, Deery A, Wilson P, Williamson P, Pitkin L. Investigatin strategy in the management of metastatic adenocarcinoma of unknown primary presenting as cervical lymphadenopathy. Acta Otolaryngol. 2014;134(8):838–42.PubMedCrossRef Pepper C, Pai I, Hay A, Deery A, Wilson P, Williamson P, Pitkin L. Investigatin strategy in the management of metastatic adenocarcinoma of unknown primary presenting as cervical lymphadenopathy. Acta Otolaryngol. 2014;134(8):838–42.PubMedCrossRef
80.
Zurück zum Zitat Pavlidis N, Fizazi K. Cancer of unknown primary (CUP). Crit Rev Oncol Hematol. 2005;54(3):243–50.PubMedCrossRef Pavlidis N, Fizazi K. Cancer of unknown primary (CUP). Crit Rev Oncol Hematol. 2005;54(3):243–50.PubMedCrossRef
81.
Zurück zum Zitat Luke C, Koczwara B, Karapetis C, Pittman K, Price T, Kotasek D, Beckmann K, Brown MP, Roder D. Exploring the epidemiological characteristics of cancers of unknown primary site in an Australian population: implications for research and clinical care. Aust N Z J Public Health. 2008;32(4):383–9.PubMedCrossRef Luke C, Koczwara B, Karapetis C, Pittman K, Price T, Kotasek D, Beckmann K, Brown MP, Roder D. Exploring the epidemiological characteristics of cancers of unknown primary site in an Australian population: implications for research and clinical care. Aust N Z J Public Health. 2008;32(4):383–9.PubMedCrossRef
82.
Zurück zum Zitat Shu X, Sundquist K, Sundquist J, Hemminki K. Time trends in incidence, causes of death, and survival of cancer of unknown primary in Sweden. Eur J Cancer Prev. 2012;21(3):281–8.PubMedCrossRef Shu X, Sundquist K, Sundquist J, Hemminki K. Time trends in incidence, causes of death, and survival of cancer of unknown primary in Sweden. Eur J Cancer Prev. 2012;21(3):281–8.PubMedCrossRef
83.
Zurück zum Zitat Brewster DH, Lang J, Bhatti LA, Thomson CS, Oien KA. Descriptive epidemiology of cancer of unknown primary site in Scotland, 1961–2010. Cancer Epidemiol. 2014;38(3):227–34.PubMedCrossRef Brewster DH, Lang J, Bhatti LA, Thomson CS, Oien KA. Descriptive epidemiology of cancer of unknown primary site in Scotland, 1961–2010. Cancer Epidemiol. 2014;38(3):227–34.PubMedCrossRef
84.
Zurück zum Zitat Urban D, Rao A, Bressel M, Lawrence YR, Mileshkin L. Cancer of unknown primary: a population-based analysis of temporal change and socioeconomic disparities. Br J Cancer. 2013;109(5):1318–24.PubMedCentralPubMedCrossRef Urban D, Rao A, Bressel M, Lawrence YR, Mileshkin L. Cancer of unknown primary: a population-based analysis of temporal change and socioeconomic disparities. Br J Cancer. 2013;109(5):1318–24.PubMedCentralPubMedCrossRef
85.
Zurück zum Zitat Brustugun OT, Helland A. Rapid reduction in the incidence of cancer of unknown primary: a population-based study. Acta Oncol. 2014;53(1):134–7.PubMedCrossRef Brustugun OT, Helland A. Rapid reduction in the incidence of cancer of unknown primary: a population-based study. Acta Oncol. 2014;53(1):134–7.PubMedCrossRef
86.
Zurück zum Zitat van der Waal RI, Buter J, van der Waal I. Oral metastases: report of 24 cases. Br J Oral Maxillofac Surg. 2003;41(1):3–6.PubMedCrossRef van der Waal RI, Buter J, van der Waal I. Oral metastases: report of 24 cases. Br J Oral Maxillofac Surg. 2003;41(1):3–6.PubMedCrossRef
87.
Zurück zum Zitat Thiele OC, Freier K, Bacon C, Flechtenmacher C, Scherfler S, Seeberger R. Craniofacial metastases: a 20-year survey. J Craniomaxillofac Surg. 2011;39(2):135–7.PubMedCrossRef Thiele OC, Freier K, Bacon C, Flechtenmacher C, Scherfler S, Seeberger R. Craniofacial metastases: a 20-year survey. J Craniomaxillofac Surg. 2011;39(2):135–7.PubMedCrossRef
88.
Zurück zum Zitat Varadhachary GR, Raber MN. Cancer of unknown primary site. N Engl J Med. 2014;371(8):757–65.PubMedCrossRef Varadhachary GR, Raber MN. Cancer of unknown primary site. N Engl J Med. 2014;371(8):757–65.PubMedCrossRef
89.
Zurück zum Zitat Monzon FA, Koen TJ. Diagnosis of metastatic neoplasms: molecular approaches for identification of tissue of origin. Arch Pathol Lab Med. 2010;134(2):216–24.PubMed Monzon FA, Koen TJ. Diagnosis of metastatic neoplasms: molecular approaches for identification of tissue of origin. Arch Pathol Lab Med. 2010;134(2):216–24.PubMed
90.
Zurück zum Zitat Rosenfeld N, Aharonov R, Meiri E, Rosenwald S, Spector Y, Zepeniuk M, Benjamin H, Shabes N, Tabak S, Levy A, Lebanony D, Goren Y, Silberschein E, Targan N, Ben-Ari A, Gilad S, Sion-Vardy N, Tobar A, Feinmesser M, Kharenko O, Nativ O, Nass D, Perelman M, Yosepovich A, Shalmon B, Polak-Charcon S, Fridman E, Avniel A, Bentwich I, Bentwich Z, Cohen D, Chajut A, Barshack I. MicroRNAs accurately identify cancer tissue origin. Nat Biotechnol. 2008;26(4):462–9.PubMedCrossRef Rosenfeld N, Aharonov R, Meiri E, Rosenwald S, Spector Y, Zepeniuk M, Benjamin H, Shabes N, Tabak S, Levy A, Lebanony D, Goren Y, Silberschein E, Targan N, Ben-Ari A, Gilad S, Sion-Vardy N, Tobar A, Feinmesser M, Kharenko O, Nativ O, Nass D, Perelman M, Yosepovich A, Shalmon B, Polak-Charcon S, Fridman E, Avniel A, Bentwich I, Bentwich Z, Cohen D, Chajut A, Barshack I. MicroRNAs accurately identify cancer tissue origin. Nat Biotechnol. 2008;26(4):462–9.PubMedCrossRef
91.
Zurück zum Zitat Epstein JI, Egevad L, Humphrey PA, Montironi R. Members of the ISUP Immunohistochemistry in Diagnostic Urologic Pathology Group. Best practices recommendations in the application of immunohistochemistry in the prostate: report from the International Society of Urologic Pathology consensus conference. Am J Surg Pathol. 2014;38(8):e6–19.PubMed Epstein JI, Egevad L, Humphrey PA, Montironi R. Members of the ISUP Immunohistochemistry in Diagnostic Urologic Pathology Group. Best practices recommendations in the application of immunohistochemistry in the prostate: report from the International Society of Urologic Pathology consensus conference. Am J Surg Pathol. 2014;38(8):e6–19.PubMed
92.
Zurück zum Zitat Reuter VE, Argani P, Zhou M, Delahunt B. Members of the ISUP Immunohistochemistry in Diagnostic Urologic Pathology Group. Best practices recommendations in the application of immunohistochemistry in the kidney tumors: report from the International Society of Urologic Pathology consensus conference. Am J Surg Pathol. 2014;38(8):e35–49.PubMed Reuter VE, Argani P, Zhou M, Delahunt B. Members of the ISUP Immunohistochemistry in Diagnostic Urologic Pathology Group. Best practices recommendations in the application of immunohistochemistry in the kidney tumors: report from the International Society of Urologic Pathology consensus conference. Am J Surg Pathol. 2014;38(8):e35–49.PubMed
93.
Zurück zum Zitat Dragomir A, de Wit M, Johansson C, Uhlen M, Pontén F. The role of SATB2 as a diagnostic marker for tumors of colorectal origin: results of a pathology-based clinical prospective study. Am J Clin Pathol. 2014;141(5):630–8.PubMedCrossRef Dragomir A, de Wit M, Johansson C, Uhlen M, Pontén F. The role of SATB2 as a diagnostic marker for tumors of colorectal origin: results of a pathology-based clinical prospective study. Am J Clin Pathol. 2014;141(5):630–8.PubMedCrossRef
94.
Zurück zum Zitat Chu P, Wu E, Weiss LM. Cytokeratin 7 and cytokeratin 20 expression in epithelial neoplasms: a survey of 435 cases. Mod Pathol. 2000;13(9):962–72.PubMedCrossRef Chu P, Wu E, Weiss LM. Cytokeratin 7 and cytokeratin 20 expression in epithelial neoplasms: a survey of 435 cases. Mod Pathol. 2000;13(9):962–72.PubMedCrossRef
Metadaten
Titel
Metastatic Tumors to the Jaws and Mouth
verfasst von
Abraham Hirshberg
Raanan Berger
Irit Allon
Ilana Kaplan
Publikationsdatum
01.12.2014
Verlag
Springer US
Erschienen in
Head and Neck Pathology / Ausgabe 4/2014
Elektronische ISSN: 1936-0568
DOI
https://doi.org/10.1007/s12105-014-0591-z

Weitere Artikel der Ausgabe 4/2014

Head and Neck Pathology 4/2014 Zur Ausgabe

Update in Gnathic Pathology. Guest Editors: Angela Chi, DMD and John Wright, DDS

Bone- and Cartilage-Forming Tumors and Ewing Sarcoma: An Update with a Gnathic Emphasis

Update in Gnathic Pathology. Guest Editors: Angela Chi, DMD and John Wright, DDS

An Update on Gnathic Pathology

Update in Gnathic Pathology. Guest Editors: Angela Chi, DMD and John Wright, DDS

Recent Developments in Metabolic Bone Diseases: a Gnathic Perspective

Update in Gnathic Pathology. Guest Editors: Angela Chi, DMD and John Wright, DDS

Fibro-Osseous Lesions of the Craniofacial Skeleton: An Update

Update in Gnathic Pathology. Guest Editors: Angela Chi, DMD and John Wright, DDS

Odontogenic Tumors, WHO 2005: Where Do We Go from Here?

Update in Gnathic Pathology. Guest Editors: Angela Chi, DMD and John Wright, DDS

Malignant Odontogenic Tumors: An Update on Selected Tumors

Neu im Fachgebiet Pathologie